Warsaw

One of the largest biopharmaceutical manufacturing sites in central Europe.

Poland’s leading biomanufacturing site

Located in Poland’s capital, Warsaw, and built to serve the growing global demand for biopharmaceuticals is our commercial-scale GMP production facility. It is one of the largest and newest facilities of its kind in Europe. The site adds significant drug substance manufacturing capacity for both commercial and clinical supply at 2000 L scale and also includes a range of single use bioreactors from 50-500 L aimed at supporting clinical trial supply.

The site is truly international with experienced professionals from major global biotechnology companies. The site is also employing and training the next generation of scientist and engineers alongside a huge support team in logistics, quality, human resources and commercial operations.

Large scale facility for drug substance manufacturing and sterile fill & finish

  • One of the most advanced biotech laboratories in Europe.
  • Designed to supply products for commercial supply and clinical trials.
  • Over 30,000 m2 commercial-scale GMP production facility.
  • Highly experienced team in manufacturing, maintenance, QA, QC and TR&D.
  • Fantastic career progression opportunities at a rapidly growing site.

Why Warsaw?

Convenient transportation hub (our Duchnice plant is just 17 km from Warsaw Chopin Airport).

  • Rich history and stunning architecture.
  • Burgeoning business landscape and economy.
  • Cultural center full of leisure opportunities, great restaurants and historical sites.
  • Top-quality international schools for children.
  • Tremendous spaces of lush greenery and fantastic parks.

Polpharma biologics offers relocation packages for experienced professionals looking to join us in Warsaw, find out about available jobs here.

Other sites

Polpharma Biologics has three international sites, two in Poland and one in the Netherlands. All three collaborate closely to provide truly integrated drug development solutions.

Gdańsk

Our Gdansk site includes mammalian and microbial R&D and manufacturing facilities for mid-scale production including drug product and fill finish.

Learn more
Utrecht

Our Utrecht site is one of innovation and leads the discovery, optimization and development of novel biologics and biosimilars as well as being home to our industry leading cell line development platform.

Learn more
Gdańsk

Our Gdansk site includes mammalian and microbial R&D and manufacturing facilities for mid-scale production including drug product and fill finish.

Learn more
Utrecht

Our Utrecht site is one of innovation and leads the discovery, optimization and development of novel biologics and biosimilars as well as being home to our industry leading cell line development platform.

Learn more

Let’s collaborate and create quality biologics together.

Get in touch for more information.

We use cookies

Polpharma Biologics uses cookies and other similar technologies (hereinafter: cookies) on its webpages and mobile applications (hereinafter, jointly, Website). The user can manage cookies independently by changing the web browser settings. If you do not consent for your personal data to be collected via cookies, you should change your web browser settings or stop using the Website.

Using the Website without changing the web browser settings indicates your acceptance of the use of cookies by Polpharma. Acceptance of the web browser settings indicates your consent to profiling on the basis of the information contained in cookies. Consent may be withdrawn at any time. Withdrawal of consent does not affect lawfulness of any processing activities carried out under consent before its withdrawal.

For more details see the Cookie Policy.